Itaconate controls the severity of pulmonary fibrosis. (2020)
Attributed to:
Imperial College London – Confidence in Concept 2019
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1126/sciimmunol.abc1884
PubMed Identifier: 33097591
Publication URI: http://europepmc.org/abstract/MED/33097591
Type: Journal Article/Review
Volume: 5
Parent Publication: Science immunology
Issue: 52
ISSN: 2470-9468